1. Home
  2. PLSE vs MGNI Comparison

PLSE vs MGNI Comparison

Compare PLSE & MGNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$25.34

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Magnite Inc.

MGNI

Magnite Inc.

HOLD

Current Price

$14.65

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLSE
MGNI
Founded
2014
2007
Country
United States
United States
Employees
N/A
514
Industry
Medical/Dental Instruments
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
PLSE
MGNI
Price
$25.34
$14.65
Analyst Decision
Buy
Strong Buy
Analyst Count
1
9
Target Price
$22.00
$25.22
AVG Volume (30 Days)
351.3K
2.6M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
493.75
EPS
N/A
0.03
Revenue
N/A
$156,414,000.00
Revenue This Year
$840.00
$6.28
Revenue Next Year
$287.54
$9.76
P/E Ratio
N/A
$479.17
Revenue Growth
N/A
25.45
52 Week Low
$12.56
$10.82
52 Week High
$27.98
$26.65

Technical Indicators

Market Signals
Indicator
PLSE
MGNI
Relative Strength Index (RSI) 56.83 64.38
Support Level $17.58 $13.61
Resistance Level $27.14 $15.25
Average True Range (ATR) 1.88 0.70
MACD 0.08 0.10
Stochastic Oscillator 67.93 90.96

Price Performance

Historical Comparison
PLSE
MGNI

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

About MGNI Magnite Inc.

Magnite is a supply-side advertising platform that provides technology and yield management solutions to content publishers, enabling them to monetize their digital advertising inventory. Magnite receives a percentage of all advertising inventory that it sells. 43% of Magnite's revenue is derived from connected television, or CTV, streaming platforms, 40% from mobile applications, and the remainder from general websites. Beyond the typical monetization responsibilities inherent to an SSP, Magnite also provides upstream advertising servers to CTV publishers, allowing them to have granular control over direct-sold, programmatic guaranteed, and open-auction logic. Magnite competes with other independent SSPs, supply path optimization solutions, and closed ecosystems like Meta.

Share on Social Networks: